|
Professor MSc. (Chemistry), Ph.D. ( Medicinal Chemistry) , CChem FRSC (U.K).
Field of interest: Drug Addiction A. Drug Analysis B. Neuro-Psychopharmacology (Preclinical) C. Abuse liability studies of psychotropic drugs D. Validity of drug use reporting and pattern of drug abuse among drug users E. Tobacco cessation programme
Total number of Publications till to date: 66 Nos.
Paper presented in National and International Conferences and abstracts published: 58 Nos.
Details of publication from yr. 2000 onwards till to date:
1. Jain, R. Utility of Thin Layer Chromatography for Detection of Opioids and Benzodiazepines in a Clinical Setting. Addict. Behav, 25, 451-454 (2000). 2. Jain, R. Effects of Diazepam and Buprenorphine on Suppression of Withdrawal Syndrome in Rats. Ind. J. Pharmacol. 32; 63 (2000). 3. Ballakoor, K., Ray, R., Dube, S., Jain, R., Vaswani, M., Dhawan, A., An Experimental Study of Tolerance among Alcohol Dependent Individuals. Ind. J. Med Res. 113, 26-31 (2001). 4. Singh, R.K.L., Jain, R., Ray, R., Gupta, Y.K. Abuse Liability of Diazepam through Different Routes. Ind. J. Physiol. Pharmacol. 45, 181-190 (2001).
5.
Jain, R.,
Tripathi, B.M., Singh, R. Assessment of Drug Use: Comparison of
Reported Drug Use and Urinalysis. NMJI, 14, 146 (2001). 6. Jain, R., Dhawan, A., Kumar, R., Ray, R., Singh, R. Patients in Treatment Centres: Are they all Dependent. Ind. J. Psy. 43, 328-330 (2001). 7. Jain, R. Role Of Dopaminergic Drugs In Nicotine Tolerance: A Pre-Clinical Study. Ind. J. Psy. 43 (2001). 8. Jain, R., Varma. S., Mohan, D. Effect of Selective Dopaminergic Drugs in Nicotine Tolerant Rats. Drug. Alcohol. Depend. 63, S72 (2001). 9. Prasad, P.S, Ray, Jain, R. R., Chavan, B.S. Abuse Liability of Nitrazepam Among Experienced Drug Users. Ind. J. Pharmacol. 33; 357-362 (2001). 10. A. Dhawan, Jain, R., Maullick, P. Comparison of Accuracy of Self-report and Urinalysis Results in Opiate Dependent Subjects. Ind. J. Pharmacol. 34: 130-132 (2002). 11. Jain, R. A Pilot Study of the Consistency of Self- reported Drug Use and Urinalysis Results. Drug. Alcohol. Depend. 66, S84 (2002). 12. Jhingan, H.P., Jain, R., Desai N.G., Vaswani, M., Tripathi, B. M., Pandey, R.M. Validity of Self- Report of Recent Opiate Use in Treatment Setting. Ind. J. Med. Sci. 56: 495-500 (2002). 13. Jain, R., Ray, R. Blocking of Enhanced Sensitivity to Behavioral Effects of Naloxone Induced by Narcotic Agonists in Rats. Ind. J. Physiol. Pharmacol. 47: 407-414 (2003). 14. Jain, R., Mukherjee, K. Biological Basis of Nicotine Addiction. Ind. J. Pharmacol. 35: 281-289 (2003). 15. Jain, R. Self-reported Drug Use and Urinalysis Results. Ind. J. Physiol. Pharmacol. 48: 106-110 (2004). 16. Jain, R. Mukherjee, K., Mohan, D. Evidence for a role of nitric oxide in nicotine precipitated withdrawals in the rat. Nic. Tob. Res. 6: 873 (2004). 17. Jain, R. Mukherjee, K. , Rajvir, S. Influence of sweet tasting solutions on opioid withdrawal. Brain. Res. Bull. 64: 319-322 (2004). 18. Jain, R., Holtzman, S.G. Caffeine Induces Differential Cross-tolerance to the Amphetamine-like Discrimination Effects of Dopaminergic Drugs. Brain. Res. Bull. 65: 415-421 (2005). 19. Prasad, HRY., Khaitan, BK., Ramam, R., Sharma, VK., Pandhi, RK., Agarwal, S., Dhawan, A., Jain, R. Diagnostic Clinical Features of Pentazocine Induced Ulcers. Int. J. Dermato. 44: 910-915 (2005) 20. Jain, R., Varghese, S.T. Diagnostic usefulness of liver function tests in alcohol and opoid dependent patients. Addit. Disoder. Their. Treat. 4: 117-120 (2005). 21. Malhotra, S., Jain, R., Varghese, S.T. Effectiveness and compliance of naltrexone in opioid-dependent patients: A pilot studt from India. Addit. Disoder. Their. Treat. 5: 129-132 (2006). 22. Jain, R., Tripathi, B.M., Varghese, S.T., Kumar, N., Kumar, M. Can you Trust Self-reports among Injectable Drug users in Clinical Setting? J. Subs. Use. 11: 431-436 (2006). 23. Singhal A., Tripathi BM., Pal HR, Jena R., Jain, R. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance. Addict Behav. 32: 320-331 (2007). 24. Jain, R., Mukherjee, K., Mohan, D. Effects of nitric oxide synthase inhibitors in attenuating the nicotine withdrawals in rats. Pharmacol. Biochem. Behav. 88: 473-480 (2008). 25. Jain, R., Mukherjee, K., Balhara, Y.P.S. The Role of NMDA Receptor Antagonists in Nicotine Tolerance, Sensitization, and Physical Dependence: A Preclinical Review. Yonsei Med J 49: 175-188 (2008). 26. De, Shantanu., Jain, R., Ray R., Dhawan, A., Varghese, S.T. Assessment of Differential Doses of Buprenorphine for long Term Pharmacotherapy among opiate Dependent Subjects. Ind. J. Physiol. Pharmacol. 52: 53-63 (2008). 27. Jain, R. Book Review entitled “WHO expert Committee on Drug Dependence, Thirty-fourth Report”. Indian J Med Res 127: 96-97 (2008). 28. Singhal A, Tripathi BM, Pal HR, Jena R, Jain R. Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance. Journal of opioid Management , 4: 41-47 (2008). 29. Jain, R., Balhara, Y.P.S. Neurobiology of Cannabis Addiction. Ind. J. Physiol. Pharmacol. 52: 217-232 (2008). 30. Zolkowska, D., Jain, R., Rothman, RB., Partilla, J.S., Roth, BL., Setola, V., Prisinzano, T.E., Baumann, M.H. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J. Pharmacol.Exp. Ther. 329: 738-746 (2009).
Chapter in Books 1. Jain, R., and Sherma, J. Planar Chromatography in Clinical Chemistry In: Encyclopedia of Analytical Chemistry Instrumentation And Applications, Meyer, R.A. (ed), John Wiley & Sons Ltd, Chichester, pp 1583-1603 (2000). 2. Ray, Jain, R. R. Mongia, M. and Kumar, R. Substance Abuse in Young People: Biological Considerations. In Mental Disorders in Children and Adolescents: Need and Strategies for Intervention, CBS Publishers, New Delhi, pp 82-87 (2005). 3. Jain, R, Role of Laboratory Services In: Lal R (Ed). Substance Abuse Disorder: Manual for Physicians, National Drug Dependence Treatment Centre, All India, Institute of Medical Sciences, New Delhi, 2005: pp127-137. 4. Jain, R. Role of Laboratory Services in Management of Substance Use Disorder In: Lal R., Gupta S. (Eds). Substance Abuse Disorder: Manual for Nurses, National Drug Dependence Treatment Centre, All India, Institute of Medical Sciences, New Delhi, 2007: 169-181 Editor: and Author
1. Jain, R., and Shantanu De. Buprenorphine – Pharmacology, Pharmacokinetics and Therapeutic Potential. In: Proceedings on National Workshop on Treatment of Opiate Dependence with Special Focus on Maintenance Therapy. Jain, R., and Dhawan, A. (ed.). Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, pp,47-53 (2000). 2. Jain, R., and Mukherjee, K. Biological Theories of Tobacco abuse. In: Proceedings of the workshop on assessment of tobacco as a gateway substance and information available on evidence relating to tobacco, alcohol and other forms of substance abuse (Eds. Dhawan A, Jain, R., Kumar, N.), New Delhi, India: Centre for Behavioral Sciences, AIIMS, sponsored by WHO India, & MOH & FW, GOI, pp. 33-38 (2004).
Monograph 1. Dhawan A, Jain R, Chopra A. Opioid Substitution- Buprenorphine in India, New Delhi: UNODC (ROSA), 2010.
Abstract Published from yr. 2000 onwards till to date:
1. Assessment of Drug Use: Comparision of Reported Drug Use and Urinalysis. Jain, R. B. M. Tripathi, (Abstract) in Annual National Conference of Indian Psychiatric Society, Cochin, (20-23 rd Jan. 2000). 2. Buprenorphine: Pharmacology, Pharmacokinetics and Theurapeutic Potential, Jain, R. (invited talk) in National workshop on Treatment of opiate Dependence Disorder with Special Focus on Maintenance Programme, De-addiction Centre, AIIMS, New Delhi, (17-18th April, 2000). 3. Role of Mass Spectrometry in Detection of Drugs of Abuse, Jain, R. (invited talk) in 9th ISMAS Workshop on Mass Spectrometry, Goa (12-16th Dec. 2000). 4. Role of Dopaminergic Drugs in Nicotine tolerance: A Pre-clinical Study, Jain, R. S. Varma, D. Mohan, (Abstract) in Annual Conference of Indian Psychiatric Society, Pune, (9-12th, Jan, 2001). 5. Assessment of Tolerance and Dependence: Pre-clinical Aspect, Jain, R. (invited talk) in Annual Conference of Neuro-science, Lucknow (29-30th Jan. 2001). 6. Tolerance and Dependence: Preclinical Aspect, Jain, R. (invited talk) in AIIMS - NIAAA Workshop on Substance Use Disorder, Drug Dependence Treatment Centre, AIIMS, New Delhi (6th March, 2001). 7. Enhanced Sensitivity to Behavioral Effects Of Naloxone. Jain, R. R.Ray in 6th NIDA / INVEST Meeting on Building International Research on Drug Abuse: Children and Youth at Risk at Scottsdale, Arizona, USA (June, 14-16th, 2001). 8. Effect of Selective Dopaminergic Drugs in Nicotine Tolerant Rats. Jain, R., Varma, S. Mohan D. Jain, R. in College on Problems of Drug Dependence, 63rd Annual Scientific Meeting, Scottsdale, Arizona, USA (June, 16-21st, 2001). 9. Evidence for an Involvement of D2 Dopamine Receptor in Mediating Nicotine Tolerance in Rats Jain, R. S. Varma, D. Mohan in Annual Meeting of Society for Research & Tobacco (SRNT) at Savannah, Georgia, USA, dated (February 20 – 23, 2002). 10. Clinical Utility of Drug Abuse Testing : Self Report Vs. Urinalysis. Jain, R. in 9th Asian Pacific Congress of Clinical Biochemistry, New Delhi. dated (March 9-14th, 2002). 11. A Pilot Study on the Consistency of Self-Reported Drug Use and Urinalysis. Jain, R. in College on Problems of Drug Dependence, 64th Annual Scientific Meeting, Quebec City, Canada (June, 8-13, 2002). 12. Comparison of Patient self-Reports and Urinalysis in the Community outreach Clinic, Jain, R. B. S. Chavan in 7th NIDA / INVEST Meeting on Building International Research on Drug Abuse: Treatment Innovations, Quebec City, Canada (June, 13-15th, 2002). 13. Biological Theories of Tobacco Abuse , Jain, R. in workshop on Assessment of Tobacco as a Gateway substance and Information on evidence relating to Tobacco, Alcohol and other Forms of Substance Abuse, All India Institute of medical Sciences, New Delhi (Sept, 4-5th, 2002). 14. Effects of Dopaminergic Drugs in Nicotine Tolerant Rats, Jain, R. S. Varma, D. Mohan, in 2nd World Assembly on Tobacco Counters Health, New Delhi, India (Sept., 29th- 3rd Oct 2002). 15. Self-Reported Drug use Among Injectable Drug Users, Jain, R. B. M. Tripathi, S. Singh, N. Kumar, M. Kumar in 2nd International Conference On HIV and Substance Abuse , HOPE 2002 , Mumbai, India (Dec 1-3rd, 2002). 16. Role of liver Function Tests in Assessment of Alcoholics and Opioid Addicts. Jain, R. R. Singh in 2003 NIDA International Forum, Building International Research: Emerging Trends and patterns in Drug Abuse Around the World. Miami, Florida (June, 13-19th, 2003). 17. Moderate Drinking-Preclinical Aspects. Jain, R. (invited talk) In National Workshop on Responsible Drinking- Review of Evidence and Formulation of Recommendations, National Drug Dependence Treatment Centre, AIIMS, New Delhi (Sept, 1-2nd, 2003). 18. Evidence for a Role of Nitric Oxide in Nicotine Precipitated Withdrawal in the Rat. Jain, R. K. Mukherjee, D. Mohan in Fifth European Conference of the Society for Research on Nicotine and Tobacco at Padua, Italy (Nov, 18- 24th, 2003). 19. Tobacco and Nicotine Related Studies at National Drug Dependence Treatment Centre, AIIMS: An overview. Jain, R. in Fifth European Conference of the Society for Research on Nicotine and Tobacco at Padua, Italy (Nov, 18- 24th, 2003). 20. Influence of Sweet tasting solution in morphine withdrawal - A pilot study Jain, R. K. Mukherjee., In XXXVI Annual Conference of Indian Pharmacological Society, New Delhi ( Dec, 5-7th, 2003). 21. Effect of Nitric Oxide Synthase Inhibitors in Nicotine Precipitated Withdrawal Rats. Jain, R. K. Mukherjee., In World Assembly on Tobacco Counters Health, New Delhi (March, 7-11th, 2004). 22. Role of sweet tasting solution in opiate withdrawal. Jain, R. K. Mukherjee., In Satellite Meeting of 2004 NIDA international Forum: Progress through Collaboration, San Juan, Puerto Rico (June 11-14th, 2004). 23. Effects of the NMDA receptor antagonists (Ketamine) to the operant decrement produced by naloxone in morphine - treated rat. Jain, R. In 66th Annual Scientific Meeting of College on Problem of Drug dependence, San Juan, Puerto Rico (June 12- 17th, 2004). 24. Effect of nitric oxide synthase inhibitors in nicotine dependent rats Society for Research on Nicotine and Tobacco’s: Jain, R. . In 11th Annual Meeting held jointly with the 7th SRNT European Conference’ (20-23 rd March, 2005) at Prague ‘Czech Republic’. 25. Drunken Driving. Jain, R. (invited talk). In. Workshop on Road Rage: A study of Aggressive behavior and intervention strategies Deptt. of Psychiatry, AIIMS, New Delhi. (May 4rth, 2005). 26. Role of laboratory in Primary Health Care. Jain, R. (invited talk). In. Workshop on Managing Alcohol Abuse in Primary Care Setting: A study of Aggressive behavior and intervention strategies, National Drug Dependence Treatment Centre, AIIMS, New Delhi. (June 17th-18th, 2005). 27. Comparison of the effects of nitric oxide synthase inhibitors in nicotine dependent rats. Jain, R. K. Mukherjee, D. Mohan. In Satellite meeting of 2005 NIDA International Forum: Linking Drug Abuse and HIV/AIDS in conjuction with 67-th Annual Scientific meeting of College on Problem of Drug Dependence (CPDD) (June17th-23rd, 2005), Orlando, Florida, USA. 28. Can you Trust Self-reports among Injectable Drug users in Clinical Setting? Jain, R., Tripathi, B.M., Varghese, S.T., Kumar, N., Kumar. In 6th NIDA/INVEST Meeting on International Trends and Needs in Drug Abuse Research at Scottsdale, Arizona, USA (June, 16-19th, 2006). Scottsdale, Arizona, USA. 29. Patterns of Drug Use: Role of Urine Testing. Jain, R. Sethi Hem. In International Symposium on Forensic Science at Amity Institute of Advance Forensic Science Research and Training (1-4 August. 2007) Noida, UP, India. 30. Concordance between Urinary cotinine levels and self-reported tobacco use among drug dependents: A Pilot study. Jain, R., Balhara, Y.P.S., Jhanjee S., Sethi, H.S. In 5th World Assembly on Tobacco Counters Health, New Delhi (Dec.2-5th, 2007). 31. Comparison of Self-Report of Tobacco Use and Urinary Cotinine Levels among Drug Dependents: A Pilot Study. Jain, R., Balhara, Y.P.S., Jhanjee S., Sethi, H.S. In 14th Annual Meeting February of Society for Research on Nicotine and Tobacco at Portland, Oregon, USA (27th Feb - 1st March, 2008). 32. Role of urine testing in evaluation of illicit drug use and ensuring compliance in opioid dependent subjects maintained on sublingual buprenorphine substitution therapy. Jain, R., Balhara, Y.P.S. In 10th Annual Meeting for the International Society of Addiction Medicine, Cape Town, South Africa (16-20th Nov, 2008). 33. Compliance and detection of illicit drug use among opioid dependent subjects maintained on sublingual buprenorphine substitution therapy. Jain, R., Balhara, Y.P.S. In International Conference of Translation Pharmacology and 41st Annual Conference of Indian Pharmacological Society, (18-20th Dec. 2008), AIIMS, New Delhi. 34. Role of Nitric Oxide Synthase Inhibitors in Nicotine Dependent Rats. Jain, R., Mukherjee, K., Mohan D. In: National Symposium on Emerging Trends in Nitric Oxide Research, (12th Jan, 2009), Vallabhai Patel Chest Institute, University of Delhi. 35. Participated in “Regional Advocacy Workshop on “Tobacco Control Law & Measures” scheduled on 16-17 Jan 2009 at Chandigarh in collaboration with MOH & FW, GOI. 36. Participated in “14th World Conference on Tobacco or Health” on 8-12th March 2009 at the National Centre for Performing Arts Mumbai, India. 37. Effects of Nitric Oxide Synthase Inhibitor to the Operant Decrement produced by Naloxone in Morphine Dependent Rats. Jain, R., In: 2nd Annual International Drug Abuse Research Society (IDARS) & International Society for Neurochemistry Satellite Meeting In Association with Korean Society for Drug Abuse Research (17-21st August, 2009), Grand Hyatt Hotel, Seoul, S. Korea. 38. Tobacco use: Relationship between self-report and urinary cotinine. Jain, R., Balhara, Y.P.S., Jhanjee, S., Sethi, H. In: Silver Jubilee Year Conference of the Indian Association for Social Psychiatry (16th-17th Nov.) 2009 at Lucknow. 39. Neurobiological basis of nicotine addiction: An update (invited talk). Jain, R., Chatterjee, B., In: XXVII Annual Conference of Indian Academy of Neurosciences at Jaipur (18-20th Dec. 2009). 40. Role of nitric oxide synthase inhibitors to the operant decrement produced by naloxone in morphine treated rats. Jain, R., In: “2010 NIDA International forum: Drug Abuse Research Policy and the Public Good & CPDD 72 Annual Scientist Meeting, at The Fairmont Scottsdale, Scottsdale, Arizona, USA (11-17th June, 2010). 41. Compliance of Prescribed Benzodiazepines in Alcohol and Opioid Dependent Subjects Based on Urinalysis. Jain, R., In: 10th Indo-Pacific Congress on Legal Medicine and Forensic Science at Amity University, UP (25-30th. Oct. 2010). 42. Drug Abuse Testing in Substance Abuse Treatment Program: AIIMS NDDTC Experience. Jain, R., “2nd International Conference on Medical Negligence in Medical Practice and on Recent Advances in Forensic Sciences, Medicine Toxicology at Hotel Riveriera De Goa, at Goa (20-21st Feb., 2011).
Number of Projects: Chief Investigator: 1. Jain, R., D. Mohan. Role of Dopamine in Experimentally Induced Nicotine Tolerant Rats (Council of Scientific and Industrial Research, Govt. Of India, funded, (1997-2001 completed). 2. Jain, R., R. Ray. Blocking of Enhanced Sensitivity to Behavioral Effects of Naloxone Induced by Narcotic Agonists in Rats (All India Institute of Medical Sciences, funded (1999- 2000, completed). 3. Jain, R., D. Mohan. Role of Nitric Oxide Synthase Inhibitors In Modifying Nicotine Withdrawals in Rats (Council of Scientific and Industrial Research, Govt. Of India, funded (2001- 2005, completed). 4. Jain, R. ., Effects of the NMDA Receptor Antagonist (Ketamine) to the Operant Decrement Produced by Naloxone in Morphine-treated Rats. (All India Institute of Medical Sciences, funded (2002- 2003, completed). 5. Jain, R., S. Jhanjee., V. Jain. R. Schnoll. Efficacy of Varenicline for Smokeless Tobacco ,Use in India ( National Institute on Drug Abuse funded, NIH, US Govt. in collaboration with AIIMS and UPENN (R. Schnoll, overall P.I, University of Pennsylvania) 2011-ongoing). Co-Investigator: 1. D. Mohan., Jain, R., H. Pal. Health Status of Workers with Chronic Opioid Exposure at Govt. Opium and Alkaloid Factory, Ghazipur, U.P., (Ministry of Finance, Govt. of India, funded 1998-2001, completed). 2. D. Mohan., Jain, R., H. Pal. Identification and Management of Alcohol Use Related Disorders in Districts Hospital in Goa. (WHO India, Ministry of Health, Govt. of India, funded, 2002- completed). 4. A. Dhawan., Jain, R., A. Chopra. To test the effectiveness of Oral Substitution with Buprenorphine and to establish a protocol for Oral Substitution with Buprenorphine. (UNODC, 2005-ongoing). 5. S. Jhanjee., Jain, R., H. Sethi. Rolling out of Opioid Substitution Treatment (OST) in Tihar prisons, Indi .(UNODC funded, 2008-ongoing). 6. A. Dhawan., Jain, R., D. Yadav. Effectiveness of Yoga in patients of Opiate Dependence (AYUSH, MOH & FW. GOI, 2009-ongoing).
Departmental Research Projects: Chief investigator: 1. Jain, R., R. Ray, B. M Tripathi, C. Singh. Opiate Excretion Profile among Heroin Dependent Subjects (1992-1993, completed). 2. Jain, R., N. G. Desai, H. P. Jhingan, M. Vaswani, B. M. Tripathi. Self Validation of Opiate use in Opiate Addicts. (1993-1994, completed). 3. Jain, R., A. Dhawan. Concordance between Self-reported Drug Use and Urinalysis in Opioid Dependent Subject on Maintenance in the Community (1999-2000, completed). 4. Jain R. A comparative Evaluation of Efficacy of Diazepam and Buprenorphine In Suppression of Opioid Withdrawal Signs in the Rats (1999- 2000, completed). 5. Jain R. Influence of Sweet Tasting Solutions in Morphine Withdrawal - A pilot study (2003, completed). 6. Jain R. Role of Sweet tasting Solutions in modifying the Opioid Withdrawals in rats (2004, completed). 7. Jain R. Effect of Nitric Oxide Synthase Inhibitor to the Operant Decrement Produced by Naloxone In morphine Treated Rats (2004-2006). 8. Jain R. Effect of Nitric Oxide Synthase Inhibitor 7-NI on Sensitization to the Operant Decrement Produced by Naloxone in Morphine Treated Rats. (2006- Ongoing). 9. Jain R., Jhanjee, S. Balhara, YPS, Sethi H. Validity of self-reported tobacco use among opioid dependent subjects (2007-completed). 10. Jain, R., Sethi H. Evaluation of Abuse of Prescription Drugs Among Opioid Dependent Patients Based On Urinalysis (NDDTC funded, AIIMS, 2007-completed). 11. Jain, R., Balhara, YPS, Evaluation of illicit drug use in the opioid dependent subjects maintained on sublingual buprenorphine: Role of urine screening (2007-completed). 12. Jain, R., Balhara YPS, Shamsunder S, Sagar R. Screening of tobacco use among psychiatric disorders: A pilot study based on urinalysis and self-report (2008-completed). 13. Jain R., Effect of Nitric Oxide Synthase Inhibitor L-NNA on Sensitization to the Operant Decrement Produced by Naloxone in Morphine Treated Rats. (2009- Ongoing). 14. Jain, R., Compliance of Prescribed Benzodiazepines in Alcohol and Opioid Dependent Subjects Based on Urinalysis. (2010-completed). 15. Jain, R., R, Sagar, Raman Deep Pattanayak. Validity of self-reported tobacco use among patients with bipolar disorder visiting the psychiatric disorder (2010-completed).
Co-Investigator 1. H. Pal, Jain, R. Investigation and Management of Psychotropic Substance Problems in Primary Care settings, Phase I, Pilot study (Assist, WHO, 1998, completed). 2. A. Dhawan, Jain R. Concordance between Self-Reported Drug Use and Urinalysis in Out patient Opioid Dependence subjects (1998-1999, completed). 3. S. Malhotra., Jain R. Current Pattern of Naltrexone Maintenance and Patient Compliance (2003 -2004 completed). 4. Raman Deep Pattanayak, R, Sagar, Jain R. Assessment of knowledge, attitude and perceived health risk for tobacco among patients with bipolar disorder (2010- completed).
Thesis supervised as MD/PhD
a) Chief guide for Postgraduate Medical Students M.D. Thesis – Ten b) Co-guide for Postgraduate Medical Students M.D. Thesis-Nine c) Chief guide for Ph.D Student Thesis-One d) Co-guide for Ph.D Student Thesis-One Significant Events: Awards and Honors: a. Was nominated by Government of India, under United Nations Fund for Drug Abuse Control Programme (UNDCP) and had five months advance training in ‘Analytical’ Methods of Body Fluid Analysis from September, 1990 to January, 1991 at Institute of Legal Medicine, Forensic Toxicology Laboratory University of Padova, Italy. During this period, was awarded United Nations Fellowship. b) Recipient of National Institute on Drug Abuse NIDA INVESTS FELLOWSHIP, US Govt. at Deptt. of Pharmacology, School of Medicine, Atlanta, Georgia 30322-3090 for a period of 13 months (1996-1997). c) Was elected as a Fellow of Royal Society of Chemistry, U.K and was awarded Cchem FRSC (2000). d) Recipient of National Institute on Drug Abuse (NIDA) international travel awards for presenting research papers in NIDA International conferences, USA (1999-2004, 2006). e) Recipient of Travel award to attend NIH Stigma and Global Health Conference at Bethesda, Maryland, USA (Sept. 2001). f) Recipient of Society for Research & Tobacco (SRNT) Global Network Travel award 2002 and 2003. g) Chaired the session "Glutamate -What's all the Excitement?” session in College on Problems of Drug Dependence, (CPDD), USA meeting on 15th June, San Juan, Puerto Rico, USA. h) Appointed as steering committee member of International Drugs of Abuse Research Society (IDARS) in Oct, 2004. i) Recipient of WHO/NIDA/CPDD International traveling Fellowship award for participating and presenting paper in Satellite meeting of 2005 NIDA International Forum: Linking Drug Abuse and HIV/AIDS in conjuction with 67-th Annual Scientific meeting of College on Problem of Drug Dependence (CPDD) (June17th-23rd, 2005), Orlando, Florida, USA. j) Recipient of Distinguished International Scientist Collaboration Award (DISCA), National Institute on Drug Abuse, US, Govt. USA for the year 2006 from (1/6/06-31/8/06). at 5500 Nathan Shock Drive, John Hopkins Bayview Campus, Baltimore, MD, 22124, USA. k) Was Recipient of NIDA International Travel Award for presenting papers in 6th NIDA/INVEST Meeting on International Trends and Needs in Drug Abuse Research at Scottsdale, Arizona, USA (June, 16-19th, 2006) & in College on Problems of Drug Dependence, 67rd Annual Scientific Meeting, Scottsdale, Arizona, USA (June 18th –22nd, 2006). l) Appointed as member of selection committee for convening of Departmental promotion Committee meeting for filling the post of Assistant Director (Biochemistry), CCRAS, Deptt. of AYUSH , MOH & FW, Govt. of India, April, 2006 m) Manuscript Reviewer of IJMR since 2006. n) Manuscript Reviewer of Brain Research Bulletin since 2007 o) Chaired the 3rd scientific session on 3rd August of International Symposium on Forensic Science at Amity Institute of Advance Forensic Science Research and Training (1-4 August. 2007) Noida, UP, India. p) Was Recipient of NIDA ISAM ( International Society of Addiction Medicine) Travel Award for presenting paper in 10th Annual Scientific Meeting of ISAM at Cape Town, South Africa (Nov. 17th-20th, 2008). q) Chaired the symposium on “ Substance Use disorder” of XVI National Conference of the Indian Association for Social Psychiatry (28-30th Nov. 2008), AIIMS, New Delhi. r) Chaired the Poster Session 5 of the International Conference of Translation Pharmacology and 41st Annual Conference of Indian Pharmacological Society, (18-20th Dec. 2008), AIIMS, New Delhi. s) Chaired the Scientific Session entitled “Health Effects, Screening and Biomarkers” In “14th World Conference on Tobacco or Health”, (8-12th March 2009), New Oberoi Hotel, Mumbai, India. t) Examiner Delhi University for Ph. D thesis, since 2009. u) Was nominated as a member of Technical Advisory Committee for Tobcco testing Labs in India, by Directorate General Health Services, MOH Nirman Bhawan, New Delhi.” (since 2009). v) Project Reviewer: Council of scientific & Industrial Research, (CSIR), Human Resource development group, Extra mural research Division, Govt. of India, New Delhi, since 2010. w) Was Recipient of NIDA International Travel award for participating and presenting paper in “2010 NIDA International forum: Drug Abuse Research Policy and the Public Good & attending CPDD 72 Annual Scientist Meeting, at The Fairmont Scottsdale, Scottsdale, Arizona, USA (11-17th June, 2010). x) Chaired the session “Forensic Toxicology” session in 10th Indo-Pacific Congress on Legal Medicine and Forensic Science on 27/10/2010 at Amity University, UP (25-30th. Oct. 2010). y) Chaired the session “ Alternate Matrices Regional Thoughts & Future Direction.” in “2nd International Conference on Medical Negligence in Medical Practice and on Recent Advances in Forensic Sciences, Medicine Toxicology at Hotel Riveriera De Goa, at Goa ( 20-21st Feb., 2011). Others: 1. Planned and Established the Drug Abuse Testing Laboratory at De-Addiction Centre of All India Institute of Medical Sciences, New Delhi, India. This is the first time such a laboratory has been established in the country. The laboratory started functioning in June 1989. 2. Officer- Incharge of Drug Abuse Testing laboratory at the National Drug Dependence Treatment Centre, AIIMS. Drug Tests in body fluid includes (screening and confirmation) for: opioids (morphine, heroin, codeine, dextropropoxyphene, pentazocine, buprenorphine), opioid antagonists (naloxone, naltrexone), benzodiazepines (diazepam, oxazepam, chlordiazepoxide, nitrazepam), Barbiturates, cannabinoids, anitihistaminics (pheniramine, promethazine), cocaine and nicotine (cotinine), inhalants (Toluene) . Every year approximately 19000 drug tests (drugs of abuse) are screened in urine samples under my supervision. 3. Apart from post graduate teaching also imparting training of Drug Abuse Testing in body fluids to Laboratory personnel’s, Doctors, Nurses of various States of the country. 4. Planned and Established a ‘Pre-clinical Behavior Laboratory in the department, for carrying out pre-clinical studies. The laboratory started functioning in 1994. 5. Membership of Scientific Societies: National: Five; International: Eight 6. Chief Coordinator for organising National workshop on Treatment of Opiate Dependence Disorder with Special Focus on Maintenance Programme, De-addiction Centre, AIIMS, New Delhi, (17-18th April, 2000).
|
